Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ACVRL1,Serine/threonine-protein kinase receptor R3,17009,63,5.00 [2.67-9.39],5.169784761457881e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14555,58,3.40 [2.26-5.11],3.895524027382406e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14555,58,2.94 [1.95-4.43],2.809336710832392e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",AMBP,Protein AMBP,17296,65,12.36 [4.36-35.05],2.280875602815373e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ATRAID,All-trans retinoic acid-induced differentiation factor,14927,60,1.98 [1.54-2.56],1.0819704005680614e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",B2M,Beta-2-microglobulin,14996,59,1.85 [1.47-2.32],1.04471608101596e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",BAMBI,BMP and activin membrane-bound inhibitor homolog,16787,65,3.21 [1.97-5.24],2.846638799386539e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",BTN2A1,Butyrophilin subfamily 2 member A1,17243,65,4.51 [2.42-8.43],2.277135420564427e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",C1QA,Complement C1q subcomponent subunit A,17313,65,6.07 [3.60-10.25],1.446244442014959e-11
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CALCB,Calcitonin gene-related peptide 2,14932,59,2.22 [1.66-2.98],9.950930874565505e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD300E,CMRF35-like molecule 2,17279,65,3.16 [2.03-4.92],3.925143596180442e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CFD,Complement factor D,14996,59,3.77 [2.31-6.17],1.121750802945831e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14932,59,2.59 [1.70-3.94],8.69090378988398e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CKAP4,Cytoskeleton-associated protein 4,17303,65,2.97 [1.97-4.47],2.0090022821083178e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CLMP,CXADR-like membrane protein,17326,65,8.66 [3.93-19.08],8.485402615016118e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",COL6A3,Collagen alpha-3(VI) chain,17388,64,3.60 [2.20-5.89],3.5878073521376905e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",COLEC12,Collectin-12,17153,65,5.83 [3.02-11.26],1.541976360233986e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CST3,Cystatin-C,17241,64,4.54 [2.50-8.26],7.233376150441608e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CTSL,Cathepsin L1,17156,63,5.90 [2.82-12.34],2.4216388627014805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CTSS,Cathepsin S,13559,51,9.58 [3.83-23.95],1.3514292124462318e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",DTNB,Dystrobrevin beta,14896,59,2.39 [1.64-3.46],4.826505110092005e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EDA2R,Tumor necrosis factor receptor superfamily member 27,17326,65,3.68 [2.41-5.61],1.382189159345393e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EFNA1,Ephrin-A1,17149,65,5.62 [3.47-9.10],2.0519587561350457e-12
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EFNA4,Ephrin-A4,17009,63,3.73 [2.47-5.63],3.6081824818283605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ERMAP,Erythroid membrane-associated protein,14555,58,3.75 [2.33-6.03],5.3906526832244594e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",FGF23,Fibroblast growth factor 23,17295,65,2.02 [1.63-2.49],1.1024635534150139e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GDF15,Growth/differentiation factor 15,17388,64,2.68 [1.91-3.77],1.4443745147469761e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GFRA1,GDNF family receptor alpha-1,17305,65,6.80 [3.56-12.96],5.894819996994153e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GUCA2A,Guanylin,17088,65,4.01 [2.55-6.31],1.772919876387472e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HAVCR2,Hepatitis A virus cellular receptor 2,17180,65,3.41 [2.13-5.45],3.1248422899799776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14555,58,3.00 [1.84-4.87],9.569432326570906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HSPB6,Heat shock protein beta-6,17326,65,2.76 [1.77-4.33],8.79638065261716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,17062,64,4.14 [2.32-7.39],1.454007294779211e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",IGFBP4,Insulin-like growth factor-binding protein 4,16976,65,3.14 [2.30-4.28],5.113229641627945e-13
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",INHBB,Inhibin beta B chain,14657,58,3.03 [2.02-4.55],8.385830866922555e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",JAM2,Junctional adhesion molecule B,17338,66,5.75 [3.26-10.13],1.436820550992595e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",KLK4,Kallikrein-4,17326,65,1.76 [1.38-2.25],5.427881294953762e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LAYN,Layilin,17014,63,4.07 [2.50-6.62],1.5205455664479072e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LTBP2,Latent-transforming growth factor beta-binding protein 2,17388,64,3.83 [2.14-6.85],6.093442100393771e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LY6D,Lymphocyte antigen 6D,17068,65,2.50 [1.76-3.55],2.7473601545024786e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",MMP12,Macrophage metalloelastase,17190,64,2.28 [1.60-3.26],5.180598465819656e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NECTIN4,Nectin-4,17214,65,3.93 [2.53-6.11],1.2002535798952683e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NEFL,Neurofilament light polypeptide,16775,63,2.65 [1.96-3.58],2.0304207389650766e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NOS1,"Nitric oxide synthase, brain",16824,63,1.89 [1.46-2.44],9.559832178466802e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NPC2,NPC intracellular cholesterol transporter 2,14729,57,2.58 [1.75-3.80],1.8648609894138889e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NPDC1,Neural proliferation differentiation and control protein 1,17156,63,3.02 [1.93-4.72],1.307371155000716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",OGN,Mimecan,17180,65,3.09 [2.01-4.74],2.5715255702067545e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PALM,Paralemmin-1,14849,60,4.89 [2.76-8.67],5.5343989585388826e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PENK,Proenkephalin-A,14657,58,4.53 [3.12-6.58],1.6674128236171125e-15
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PGF,Placenta growth factor,17395,66,4.28 [2.70-6.78],6.105756772801483e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PHLDB1,Pleckstrin homology-like domain family B member 1,14927,60,2.38 [1.62-3.48],9.046621477418769e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,17180,65,5.21 [3.17-8.56],8.041205380081631e-11
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PRELP,Prolargin,17153,65,4.39 [2.36-8.15],2.826615611780837e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PSAPL1,Proactivator polypeptide-like 1,14927,60,3.02 [2.03-4.50],4.7299519891997614e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PTGDS,Prostaglandin-H2 D-isomerase,17066,63,3.41 [2.09-5.56],8.273902976892783e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16982,63,3.91 [2.49-6.14],3.135386097446076e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RBFOX3,RNA binding protein fox-1 homolog 3,14955,59,2.32 [1.70-3.18],1.2366858177532566e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RELT,Tumor necrosis factor receptor superfamily member 19L,17180,65,4.18 [2.51-6.97],3.795493807185388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RETN,Resistin,17135,64,2.20 [1.63-2.95],1.946575812900793e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE1,Ribonuclease pancreatic,14996,60,4.88 [2.99-7.95],2.1434567461298283e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE4,Ribonuclease 4,14541,58,3.43 [2.11-5.58],7.161673044839555e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE6,Ribonuclease K6,14905,59,2.06 [1.52-2.80],3.265553438475202e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SCARB2,Lysosome membrane protein 2,16696,63,3.78 [2.47-5.78],9.99313641079557e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SEMA3G,Semaphorin-3G,14657,58,2.60 [1.72-3.93],5.784837848769812e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SFRP1,Secreted frizzled-related protein 1,16977,63,2.63 [1.99-3.47],1.0893378495320874e-11
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SHISA5,Protein shisa-5,14977,59,2.69 [1.87-3.88],1.1341256173651172e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SPINK1,Serine protease inhibitor Kazal-type 1,17180,65,4.07 [2.87-5.77],3.4552179867677428e-15
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TFF3,Trefoil factor 3,17206,63,2.36 [1.74-3.20],3.9919162571587336e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TGFBR2,TGF-beta receptor type-2,17214,65,3.79 [2.51-5.73],2.5997680078004407e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TGOLN2,Trans-Golgi network integral membrane protein 2,14996,60,7.43 [3.20-17.25],3.054363600985496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,17039,63,1.54 [1.28-1.84],3.100534394435301e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,17395,66,3.24 [2.08-5.06],2.037743895092397e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,17183,65,3.97 [2.23-7.04],2.5890128687878484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,17326,65,4.49 [2.93-6.86],4.324093020409724e-12
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,17180,65,5.23 [3.25-8.42],9.74761860657464e-12
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,17180,65,2.02 [1.54-2.64],2.930303280199205e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,17367,65,2.98 [1.97-4.52],2.531330701741916e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TSHB,Thyrotropin subunit beta,17156,63,0.47 [0.36-0.62],1.0419343615858489e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",VSIG4,V-set and immunoglobulin domain-containing protein 4,17160,65,3.86 [2.49-5.98],1.409389870210752e-09
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",WFDC2,WAP four-disulfide core domain protein 2,16339,63,2.98 [2.03-4.36],2.089812682196407e-08
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",WNT9A,Protein Wnt-9a,16901,64,2.87 [1.81-4.55],7.118320001133648e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",YAP1,Transcriptional coactivator YAP1,14932,59,5.63 [3.25-9.75],6.78132071707106e-10
